Clinical trials
Phase 2 Recurrence trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2022 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| Novartis Pharmaceuticals | 2 |
| Amgen | 1 |
| Cellectar Biosciences, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Hellenic Oncology Research Group | 1 |
| Hellenic Society of Hematology | 1 |
| Kiniksa Pharmaceuticals International, plc | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 13 |
| Multiple Myeloma | 6 |
| Neoplasms | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Blood Protein Disorders | 1 |
| Crohn Disease | 1 |
| Epstein-Barr Virus Infections | 1 |
| Head and Neck Neoplasms | 1 |
| Heart Diseases | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.